Philip D. Gregory

2019 - bluebird bio

In 2019, Philip D. Gregory earned a total compensation of $3.9M as Chief Scientific Officer at bluebird bio, a 55% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$194,600
Option Awards$2,348,552
Salary$455,000
Stock Awards$908,753
Other$11,200
Total$3,918,105

Gregory received $2.3M in option awards, accounting for 60% of the total pay in 2019.

Gregory also received $194.6K in non-equity incentive plan, $455K in salary, $908.8K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Philip D. Gregory's compensation ranked 3,062nd out of 13,971 executives tracked by ExecPay. In other words, Gregory earned more than 78.1% of executives.

ClassificationRankingPercentile
All
3,062
out of 13,971
78th
Division
Manufacturing
1,104
out of 5,701
81st
Major group
Chemicals And Allied Products
371
out of 2,200
83rd
Industry group
Drugs
305
out of 1,886
84th
Industry
Biological Products, Except Diagnostic Substances
72
out of 389
82nd
Source: SEC filing on April 27, 2020.

Gregory's colleagues

We found five more compensation records of executives who worked with Philip D. Gregory at bluebird bio in 2019.

2019

Nick Leschly

bluebird bio

Chief Executive Officer

2019

William Baird

bluebird bio

Chief Financial Officer

2019

Jeffrey Walsh

bluebird bio

Former Chief Strategy Officer

2019

David Davidson

bluebird bio

Chief Medical Officer

2019

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like